innovation, marketing, and EU MDR compliance
The EU MDR regulation requires medical device manufacturers to provide greater emphasis on clinical data and evidence to ensure that medical devices meet the highest standards of safety and efficacy. However, with such stringent requirements, medical device manufacturers may face challenges in navigating clinical data for EU MDR compliance. This webinar, hosted by Cetas Healthcare, will bring together experts from multiple domains of the EU MDR to provide practical insights on clinical data.
I have found that CETAS HEALTHCARE offers a high-quality, world-class product that is far superior to that of many other firms. I have used them for well over 10 years now, and believe that their strengths include their extensive depth in qualitative and quantitative research, as well as their ability to communicate in a clear, concise manner. In many instances, they have allowed me to experience the customer feedback and fact-gathering journey with them, and thus helped me better understand how they reached their conclusions. While many other firms might cut corners, I was always confident that their recommendations were supported by high-quality data.- VP & Managing Director APAC Oxford Immunotec Singapore
We have started working with CETAS in various complex research projects already in 2014. The studies were done in a very professional way and included various fields such as customer engagement, and product and market research. Overall, these years, CETAS delivered good results on time. Sumit and his team understood the business context very well and based on relevant data we received excellent insights. The quality of the reports was always outstanding.- Executive Vice President Global Sales & Marketing KARL STORZ SE & Co. KG
A global medical technology company developing and selling Cardiac Rhythm Disease Management, Spinal and Biologics, CardioVascular, Neuromodulation, Diabetes, and Surgical Technologies.
A global medical technology company who wants enhance customer insights quarterly to better inform the product development, marketing and commercial decisions on a consistent basis...globally.
A global healthcare company is developing a new Value Segment PET-CT system which is smart, easy to use, and affordable. The client wants to understand the current market dynamics in tier 2/3 market and understand the business opportunity for the...
September 2022 The China Peripheral Artery Disease (PAD) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with...
September 2022 Download Now The United States Peripheral Artery Disease (PAD) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary...
September 2022 Download Now The China Percutaneous Coronary Interventions (PCI) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research...